Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia

K. Burnett, Alan; H. Russell, Nigel; K. Hills, Robert; Kell, Jonathan; Freeman, Sylvie; Kjeldsen, Lars; E. Hunter, Ann; Yin, John; Craddock, Charles; Høgh Dufva, Inge; Wheatley, Keith; Milligan, Donald

doi:10.1200/jco.2012.42.2964

Public

Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia

Published in Journal of Clinical Oncology • Jul 31, 2012

Authors:

Alan K. Burnett

Nigel H. Russell

Robert K. Hills

Abstract

PURPOSE: There has been little survival improvement in older patients with acute myeloid leukemia (AML) in the last two decades. Improving induction treatment may improve the rate and quality of remission and consequently survival. In our previous trial, in younger patients, we showed improved survi...

Subject

Gemtuzumab ozogamicin

Medicine

Myeloid leukemia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!